Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.67

-2.1%

1:41 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas who wrote (80)	4/8/1997 3:00:00 AM
From: T. Mann	of 455

The product has a great hype potential (female empowering, etc.) but the market size is uncertain. (This could explain the delay). The real consumers are likely to be women in the third world with no money to buy the product. It has to be very cheap to make, otherwise some government or an international organization would have to pay the bill. Also, since the product is for prevention and not treatment, safety and a proof of efficacy may be difficult issues. IMO, Procept will not be able to complete the trials on its own. They will have to find a buyer for their compound, or a source of funds to develop it. GILD has $300mln cash. T.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next